Angiolutions secures €2.5 million European
Angiolutions secures €2.5 million European Innovation Council grant to fast-track its groundbreaking aneurysm treatment Angiolutions awarded Accelerator Grant from the
News & Updates
Angiolutions secures €2.5 million European Innovation Council grant
July 27th, 2023, Angiolutions has been awarded the prestigious European Innovation Council (EIC) Accelerator Grant and will receive €2.5 million in funding for its groundbreaking treatment for early-stage abdominal aortic aneurysms.
Angiolutions wins 1st Place in FICPI World IP Day Competition 2023
April 26, 2023: Angiolutions has won the FICPI World IP Day competition 2023, with this year’s theme being “Women and IP: Accelerating Innovation and Creativity,” honoring female inventors and their achievements.
Angiolutions wins Maxis CSI Innovator Award
December 10, 2022: Angiolutions has been honored with the Maxis CSI Innovator Award, acknowledging the company’s groundbreaking technology, remarkable potential for impact, robust IP strategy, and exceptional market potential in addressing abdominal aortic aneurysms.
Angiolutions receives ISO 13485 certification
for its fully digital quality management system
As of December 22, 2021, Angiolutions is ISO 13485 certified. This ensures highest levels of quality and patient safety in our journey to bring the first device to treat small abdominal aortic aneurysms (AAAs) to market and to help hundred thousands of patients.
Stay in touch
receive update emails a few times a year
Angiolutions in the media
Die tickende Zeitbombe
04.03.2021 | nbank.de
"Angiolutions entwickelt ein neuartiges Gefäßimplantat, das zum ersten Mal eine spezifische minimalinvasive Behandlung kleiner Bauchaortenaneurysmen ermöglicht [...]"
read more
Im Austausch mit der Gesellschaft
16.02.2021 | deutschland.de
"Medizinische Forschung: Isabel Schellinger arbeitet als Ärztin und ist Gründerin eines wissenschaftsbasierten Startups[...]"
read more
Media Kit
further content about Angiolutions
Document title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Document title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
